Ameliorative role of bioactive phytoconstituents targeting obesity associated NAFLD by modulation of inflammation and lipogenesis pathways: a comprehensive review-Reference-Cited by-同舟云学术

Ameliorative role of bioactive phytoconstituents targeting obesity associated NAFLD by modulation of inflammation and lipogenesis pathways: a comprehensive review

Published:2023-12-30 Issue: Volume: Page:
ISSN:1568-7767
Container-title:Phytochemistry Reviews
language:en
Short-container-title:Phytochem Rev

Author:

Barbhuiya Pervej Alom^ORCID,Sen Saikat^ORCID,Pathak Manash Pratim^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Plant Science,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s11101-023-09912-w.pdf

Reference210 articles.

1. Abenavoli L, Falalyeyeva T, Boccuto L et al (2018) Obeticholic acid: a new era in the treatment of nonalcoholic fatty liver disease. Pharmaceuticals 11:104. https://doi.org/10.3390/ph11040104

2. Aghamohammadzadeh N, Niafar M, Dalir Abdolahinia E et al (2015) The effect of pioglitazone on weight, lipid profile and liver enzymes in type 2 diabetic patients. Ther Adv Endocrinol 6:56–60. https://doi.org/10.1177/2042018815574229

3. Aishwarya TS, Mounika N, Vishwakarma G, Adela R (2022) Effect of obeticholic acid in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) patients: a systematic review and meta-analysis. RPS Pharm Pharmacol Rep 1:rqac001. https://doi.org/10.1093/rpsppr/rqac001

4. Akdoğan Ö, Atak Yücel A, Gök Sargin Z et al (2019) Evaluation of plasma urokinase-type plasminogen activator receptor (UPAR) in patients with chronic hepatitis B, C and non-alcoholic fatty liver disease (NAFLD) as serological fibrosis marker. J Clin Exp Hepatol 9:29–33. https://doi.org/10.1016/j.jceh.2018.02.001

5. Alcalá M, Sánchez-Vera I, Sevillano J et al (2015) Vitamin E reduces adipose tissue fibrosis, inflammation, and oxidative stress and improves metabolic profile in obesity: adipose tissue fibrosis causes insulin resistance. Obesity 23:1598–1606. https://doi.org/10.1002/oby.21135

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myrtenol: A promising terpene with potent pharmacological properties;Pharmacological Research - Natural Products;2024-09

2. A Review on in-vivo and in-vitro Models of Obesity and Obesity-Associated Co-Morbidities;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-08-12

3. Herbal tea used globally targeting metabolic syndrome: A systematic review;International Journal of Diabetes in Developing Countries;2024-06-11